We have developed therapies that give the immune system the tools to recognize and fight cancer cells. Our first class of therapies work by telling the immune system to detect and attack cancer cells, while leaving healthy cells unharmed. Our second class of therapies work by directly blocking cancer cell growth and preventing cancer from spreading.

The illustration shows how Kiromic’s investigational technology can result in the activation of killer T-cells (a specialized type of white blood cell) leading to a targeted attack on cancer cells throughout the body.

Kiromic’s technologies hold the promise of significantly helping patients suffering from life-threatening cancers.

– Robert S. Bresalier M.D. | Professor of Medicine | Distinguished Professor in Gastrointestinal Oncology | MD Anderson Cancer Center
Copyright © 2018 Kiromic. All rights reserved.